Cheng Yuexuan, Zhong Chunhong, Yan Shujing, Chen Chunli, Gao Xiaoli
College of Pharmacy, Xinjiang Medical University, Urumqi, Xinjiang, 830011, China.
Engineering Research Center of Xinjiang & Central Asian Medicine Resources, Ministry of Education, Urumqi, Xinjiang, 830011, China.
Future Med Chem. 2023 Feb;15(4):379-393. doi: 10.4155/fmc-2022-0309. Epub 2023 Mar 22.
Prodrug strategy is critical for innovative drug development. Structural modification is the most straightforward and effective method to develop prodrugs. Improving drug defects and optimizing the physical and chemical properties of a drug, such as lipophilicity and water solubility, changing the way of administration can be achieved through specific structural modification. Designing prodrugs by linking microenvironment-responsive groups to the prototype drugs is of great help in enhancing drug targeting. In the meantime, making connections between prodrugs and suitable drug delivery systems could realize drug loading increases, greater stability, bioavailability and drug release control. In this paper, lipidic, water-soluble, pH-responsive, redox-sensitive and enzyme-activatable prodrugs are reviewed on the basis of structural modification.
前药策略对于创新药物开发至关重要。结构修饰是开发前药最直接有效的方法。通过特定的结构修饰可以改善药物缺陷、优化药物的物理化学性质,如亲脂性和水溶性,改变给药方式。将微环境响应基团与原型药物相连设计前药,对增强药物靶向性有很大帮助。同时,将前药与合适的药物递送系统相结合,可以实现药物负载增加、更高的稳定性、生物利用度和药物释放控制。本文基于结构修饰对脂质前药、水溶性前药、pH响应前药、氧化还原敏感前药和酶激活前药进行了综述。